These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 34610041

  • 1. Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    Creemers RH, Rezazadeh Ardabili A, Jonkers DM, Leers MPG, Romberg-Camps MJ, Pierik MJ, van Bodegraven AA.
    PLoS One; 2021; 16(10):e0258271. PubMed ID: 34610041
    [Abstract] [Full Text] [Related]

  • 2. Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Derikx LAAP, Lantinga MA, de Jong DJ, van Dop WA, Creemers RH, Römkens TEH, Jansen JM, Mahmmod N, West RL, Tan ACITL, Bodelier AGL, Gorter MHP, Boekema PJ, Halet ERC, Horjus CS, van Dijk MA, Hirdes MMC, Epping Stippel LSM, Jharap B, Lutgens MWMD, Russel MG, Gilissen LPL, Nauta S, van Bodegraven AA, Hoentjen F.
    J Crohns Colitis; 2021 Apr 06; 15(4):529-539. PubMed ID: 33079178
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroids but not Anti-TNF Are Associated With Increased COVID-19 Complications in Patients With Inflammatory Bowel Disease.
    Long MD, Parlett L, Lewis JD, Haynes K, Adimadhyam S, Hou L, Wolfe A, Toh S, Burris J, Dorand J, Kappelman MD.
    Inflamm Bowel Dis; 2024 Aug 01; 30(8):1345-1352. PubMed ID: 37611117
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden.
    Ludvigsson JF, Axelrad J, Halfvarson J, Khalili H, Larsson E, Lochhead P, Roelstraete B, Simon TG, Söderling J, Olén O.
    United European Gastroenterol J; 2021 Mar 01; 9(2):177-192. PubMed ID: 33704918
    [Abstract] [Full Text] [Related]

  • 5. Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.
    Naseem K, Sohail A, Quang Nguyen V, Khan A, Cooper G, Lashner B, Katz J, Cominelli F, Regueiro M, Mansoor E.
    Inflamm Bowel Dis; 2024 Aug 01; 30(8):1334-1344. PubMed ID: 37725039
    [Abstract] [Full Text] [Related]

  • 6. Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.
    Opstelten JL, Vaartjes I, Bots ML, Oldenburg B.
    Inflamm Bowel Dis; 2019 Sep 18; 25(10):1692-1699. PubMed ID: 31189013
    [Abstract] [Full Text] [Related]

  • 7. Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study.
    Lee JW, Song EM, Jung SA, Jung SH, Kim KW, Koh SJ, Lee HJ, Hong SW, Park JH, Hwang SW, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK, Park SH, IBD Research Group of the Korean Association for the Study of Intestinal Diseases.
    J Korean Med Sci; 2021 Dec 13; 36(48):e336. PubMed ID: 34904410
    [Abstract] [Full Text] [Related]

  • 8. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A, COVID-19 Lombardy ICU Network.
    JAMA; 2020 Apr 28; 323(16):1574-1581. PubMed ID: 32250385
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD.
    Gastroenterology; 2020 Aug 28; 159(2):481-491.e3. PubMed ID: 32425234
    [Abstract] [Full Text] [Related]

  • 10. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S.
    United European Gastroenterol J; 2021 Mar 28; 9(2):159-176. PubMed ID: 33210980
    [Abstract] [Full Text] [Related]

  • 11. Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort.
    Romberg-Camps M, Kuiper E, Schouten L, Kester A, Hesselink-van de Kruijs M, Limonard C, Bos R, Goedhard J, Hameeteman W, Wolters F, Russel M, Stockbrügger R, Dagnelie P.
    Inflamm Bowel Dis; 2010 Aug 28; 16(8):1397-410. PubMed ID: 20027652
    [Abstract] [Full Text] [Related]

  • 12. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Jeuring SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, Romberg-Camps MJ, Oostenbrug LE, Masclee AA, Jonkers DM, Pierik MJ.
    Inflamm Bowel Dis; 2016 Jun 28; 22(6):1425-34. PubMed ID: 26933752
    [Abstract] [Full Text] [Related]

  • 13. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
    Queiroz NSF, Martins CA, Quaresma AB, Hino AAF, Steinwurz F, Ungaro RC, Kotze PG.
    J Gastroenterol Hepatol; 2021 Nov 28; 36(11):3033-3040. PubMed ID: 34151470
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System.
    Khan N, Mahmud N, Trivedi C, Reinisch W, Lewis JD.
    Gut; 2021 Sep 28; 70(9):1657-1664. PubMed ID: 33753416
    [Abstract] [Full Text] [Related]

  • 15. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease.
    Wetwittayakhlang P, Albader F, Golovics PA, Hahn GD, Bessissow T, Bitton A, Afif W, Wild G, Lakatos PL.
    Can J Gastroenterol Hepatol; 2021 Sep 28; 2021():7591141. PubMed ID: 34858891
    [Abstract] [Full Text] [Related]

  • 16. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C, Armuzzi A, Furfaro F, Ardizzone S, Milla M, Carparelli S, Orlando A, Caprioli FA, Castiglione F, Viganò C, Ribaldone DG, Zingone F, Monterubbianesi R, Imperatore N, Festa S, Daperno M, Scucchi L, Ferronato A, Pastorelli L, Balestrieri P, Ricci C, Cappello M, Felice C, Fiorino G, Saibeni S, Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
    Aliment Pharmacol Ther; 2021 Dec 28; 54(11-12):1432-1441. PubMed ID: 34694009
    [Abstract] [Full Text] [Related]

  • 17. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort.
    Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, van Deursen C, Hameeteman WH, Pierik M, Wolters F, Russel MG, Stockbrügger RW.
    Inflamm Bowel Dis; 2010 Dec 28; 16(12):2137-47. PubMed ID: 20848468
    [Abstract] [Full Text] [Related]

  • 18. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
    Murthy S, Archambault PM, Atique A, Carrier FM, Cheng MP, Codan C, Daneman N, Dechert W, Douglas S, Fiest KM, Fowler R, Goco G, Gu Y, Guerguerian AM, Hall R, Hsu JM, Joffe A, Jouvet P, Kelly L, Kho ME, Kruisselbrink RJ, Kumar D, Kutsogiannis DJ, Lamontagne F, Lee TC, Menon K, O'Grady H, O'Hearn K, Ovakim DH, Pharand SG, Pitre T, Reel R, Reeve B, Rewa O, Richardson D, Rishu A, Sandhu G, Sarfo-Mensah S, Shadowitz E, Sligl W, Solomon J, Stelfox HT, Swanson A, Tessier-Grenier H, Tsang JLY, Wood G, SPRINT-SARI Canada Investigators and the Canadian Critical Care Trials Group.
    CMAJ Open; 2021 Dec 28; 9(1):E181-E188. PubMed ID: 33688026
    [Abstract] [Full Text] [Related]

  • 19. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L, Armuzzi A, Scribano ML, Castiglione F, D'Incà R, Orlando A, Papi C, Daperno M, Vecchi M, Riegler G, Fries W, Alvisi P, Meucci G, Mocciaro F, Rogai F, Festa S, Guidi L, Testa A, Spina L, Renna S, Viola A, Patturelli M, Di Mitri R, Frankovic I, Calabrese E, Petruzziello C, De Cristofaro E, Sena G, Ruffa A, Neri B, Rossi A.
    Inflamm Bowel Dis; 2020 Feb 11; 26(3):450-459. PubMed ID: 31498388
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.